Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

749 Press Releases
DateTitleCompany
03 Dec 16 New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Pfizer Inc.,
Published by
Business Wire
01 Dec 16 LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint Pfizer Inc.,
Published by
Business Wire
30 Nov 16 Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab) Pfizer Inc.,
Published by
Business Wire
21 Nov 16 Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire Pfizer Inc.,
Published by
Business Wire
21 Nov 16 Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019 Pfizer Inc.,
Published by
Business Wire
18 Nov 16 Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019 Pfizer Inc.,
Published by
Business Wire
16 Nov 16 National Advisory Committee on Immunization (NACI) gives Prevnar® 13 Grade A recommendation Pfizer Canada Inc.,
Published by
PR Newswire
15 Nov 16 Pfizer Prices $6,000,000,000 Debt Offering Pfizer Inc.,
Published by
Business Wire
14 Nov 16 CORRECTING and REPLACING Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019 Pfizer Inc.,
Published by
Business Wire
14 Nov 16 Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers Pfizer Inc.,
Published by
Business Wire
14 Nov 16 Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019 Pfizer Inc.,
Published by
Business Wire
13 Nov 16 Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar Cardiovascular Risk As Compared To Prescription Doses Of Ibuprofen and Naproxen Pfizer,
Published by
Business Wire
11 Nov 16 Pfizer Announces Major Expansion of Humanitarian Assistance Program Pfizer Inc.,
Published by
Business Wire
02 Nov 16 Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China Pfizer,
Published by
Business Wire
01 Nov 16 Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor Pfizer Inc.,
Published by
Business Wire
31 Oct 16 European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma Merck KGaA, Darmstadt, Germany, and Pfizer,
Published by
PharmiWeb.com
20 Oct 16 CDC Advisory Committee on Immunization Practices Votes to Recommend New Dosing Schedule for Vaccination with TRUMENBA® (Meningococcal Group B Vaccine) Pfizer Inc.,
Published by
Business Wire
19 Oct 16 Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection Pfizer Inc.,
Published by
Business Wire
26 Sep 16 Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation Pfizer Inc.,
Published by
Business Wire
28 Sep 16 Pfizer Completes Acquisition of Medivation Pfizer Inc.,
Published by
Business Wire
15 Sep 16 FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (varenicline) Pfizer,
Published by
Business Wire
09 Oct 16 Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC) Pfizer Inc.,
Published by
Business Wire
16 Sep 16 Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab) Pfizer Inc.,
Published by
Business Wire
29 Sep 16 Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress Pfizer ,
Published by
PharmiWeb.com
29 Sep 16 Pfizer Completes Acquisition of Medivation Pfizer ,
Published by
PharmiWeb.com
22 Sep 16 Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend Pfizer Inc.,
Published by
Business Wire
23 Sep 16 Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation Pfizer Inc.,
Published by
Business Wire
23 Sep 16 Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend Pfizer ,
Published by
PharmiWeb.com
17 Oct 16 Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA® (infliximab-dyyb) Pfizer Inc.,
Published by
Business Wire
27 Sep 16 Pfizer Announced as Platinum Sponsor of Pharma Integrates Pfizer ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.